In ischaemic stroke, cGAS-STING silencing, AAV-NeuroD1-mediated neuronal reprogramming, and delivery of neurotrophic factors, including VEGF and BDNF, extend the therapeutic window well beyond reperfusion. This evidence concerns the gene VEGFA and ischemic stroke.